Cargando…

Hydrocephalus treatment and outcome in African infants with myelomeningocele: what we have learned so far

Detalles Bibliográficos
Autor principal:	Warf, Benjamin C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026507/ http://dx.doi.org/10.1186/1743-8454-7-S1-S3

Ejemplares similares

Recruitment to trials - why is it hard and how might we make it less so?
por: Treweek, Shaun
Publicado: (2011)

PReS13-SPK-1582: Activity and damage - we have to measure them
por: Feldman, BM
Publicado: (2013)

PReS13-SPK-1028: Activity and damage - we have to measure them
por: Brunner, H
Publicado: (2013)

Multisystem inflammatory syndrome in children and complete atrioventricular block: What have we learned so far and where do we go from here?
por: Clark, Bradley C, et al.
Publicado: (2021)

PReS13-SPK-1247: Activity and damage in juvenile systemic sclerosis- we have to measure them
por: Foeldvari, I
Publicado: (2013)

The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013)

COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020)

An infant with anaphylaxis
por: Roberts, Graham
Publicado: (2011)

Headache research - where are we heading?
por: Jensen, Rigmor
Publicado: (2013)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
por: Conde, João, et al.
Publicado: (2016)

OMICs in Cariology and Endodontology – what have we learned so far?
por: Zaura, Egija
Publicado: (2017)

Circadian Clocks in Fish—What Have We Learned so far?
por: Frøland Steindal, Inga A., et al.
Publicado: (2019)

Offline: COVID-19—what have we learned so far?
por: Horton, Richard
Publicado: (2020)

ECMO Retrieval Program: What Have We Learned So Far
por: Krasivskyi, Ihor, et al.
Publicado: (2023)

Early exposure hypothesis: where are we now?
por: Lack, Gideon
Publicado: (2011)

Do we need to demonstrate Amyloid in tissue?
por: Magy, Laurent
Publicado: (2015)

Epidemiology of food allergy in European infants
por: Beyer, Kirsten
Publicado: (2011)

Genomics-based breeding in forest trees: are we there yet?
por: Neale, David
Publicado: (2011)

Genome-forward oncology: how do we get there?
por: Ellis, Matthew
Publicado: (2011)

Immunotherapy of food allergy: what is effective?
por: Renz, Harald
Publicado: (2011)

What has changed in the diagnostic approach?
por: Fiocchi, Alessandro
Publicado: (2011)

Immunotherapy of food allergy: what is effective?
por: Sampson, Hugh
Publicado: (2011)

What is new in the treatment of eosinophilic eosophagitis?
por: Assa'ad, Amal
Publicado: (2011)

Migraine and epilepsy: what value today?
por: Costa, Cinzia, et al.
Publicado: (2015)

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
por: Westermark, Per
Publicado: (2015)

What happens after hepatitis C eradication?
por: Pol, Stanislas
Publicado: (2012)

What makes an antigen a food allergen?
por: Mills, Clare
Publicado: (2011)

Campylobacter Phage Isolation and Characterization: What We Have Learned So Far
por: Jäckel, Claudia, et al.
Publicado: (2019)

MRD Tailored Therapy in AML: What We Have Learned So Far
por: Ngai, Lok Lam, et al.
Publicado: (2021)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

Transgenic biotechnology in forestry: what a long strange trip it's been
por: Strauss, Steven H
Publicado: (2011)

PReS13-SPK-1322: Autoinflammatory in nature: what patients teach us
por: Gattorno, M
Publicado: (2013)

What does it take to be healthy? Investigating immune-deficiency in non-immunodeficient scenarios
por: Binda, Elisa, et al.
Publicado: (2012)

Congenital myelomeningocele – do we have to change our management?
por: Mayer, Steffi, et al.
Publicado: (2010)

Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

PReS13-SPK-1182: Six years of eu paediatric regulation - what was achieved for paediatric rheumatology
por: Vesely, R
Publicado: (2013)

Lessons learned from Chikungunya
por: Rezza, Giovanni
Publicado: (2010)

Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_7041a3mfrph1gur6unl621kecj